Skip to content
Search

Latest Stories

RCGP urges NHS England to confirm TERS funding for 2025/26

TERS funding 2025-26
TERS scheme attract GP trainees to economically disadvantaged areas (gettyimages)

With the vital funding yet to be confirmed, the College fears there is a “real danger” that it could be cut from April  

The Royal College of GPs (RCGP) has warned that patients in deprived areas could face even greater difficulty accessing GP services if funding for the Targeted Enhanced Recruitment Scheme (TERS) is withdrawn.

In a letter to NHS England, the College is calling for confirmation that TERS will be extended for 2025/26 and beyond.


The scheme, launched in 2016, was designed to attract GP trainees to economically disadvantaged areas, where healthcare provision has historically been inadequate.

TERS offers a one-off payment of £20,000 to GP trainees who commit to working in hard-to-recruit-to locations.  Over the years, the scheme has successfully recruited over 2,000 GPs.

However, with funding for 2025/26 yet to be confirmed, the RCGP is worried that it could be cut from April.

The College has expressed concern that discontinuing the scheme could “make it even more difficult to recruit GPs to work in deprived and under-doctored areas where patients are already significantly disadvantaged compared to those in more affluent areas of the country.”

Highlighting the UK-wide workforce crisis, RCGP pointed out that in the most deprived areas of England, there are 2,450 patients per full time, fully qualified GP – over 300 more patients per GP than in more affluent areas of the country.

The areas with the highest numbers of places available through the TERS scheme in 2024/25 were Durham and Tees Valley (60), Dewsbury, Pontefract & Wakefield (47) and Sherwood Forest (36).

Professor Kamila Hawthorne, chair of the RCGP, expressed her concerns: “It’s alarming to see a scheme that has provided our patients with much-needed access to GPs now under threat.”

“The TERS has successfully attracted thousands of GP trainees to work in areas that they might previously not have considered, and which desperately need more GPs.

“It has led to clear benefits, including improved patient access, continuity of care, and long-term workforce retention.”

Hawthorne emphasised that cutting the scheme would be a “major step backwards” for the government’s manifesto commitment to halve the gap in healthy life expectancy across the UK.

She noted that the scheme not only encourages GP trainees to take roles in more deprived areas of the country but also put down roots and become part of the community.

“The continuation of TERS is important if we are to attract and retain GPs in these areas and truly tackle health inequalities for our patients,” she added.

More For You

Professor Sir Stephen Powis at a press briefing

Professor Sir Stephen Powis, was appointed national medical director of NHS England in 2018

NHS

NHS England’s top doctor to step down following Amanda Pritchard’s resignation

Just a week after NHS England chief executive Amanda Pritchard announced her resignation, the organisation’s national medical director, Professor Sir Stephen Powis, has confirmed he will step down this summer after more than seven years in the role.

In a statement released on Thursday, Professor Powis revealed that he had informed Pritchard of his intention to leave in a letter back in January.

Keep ReadingShow less
PDA calls on GP practices to use funding boost to improve job security for pharmacists

Now, it is time to focus on the community pharmacy contract

gettyimages

PDA urges GP practices to ensure funding boost supports employed pharmacists

The Pharmacists' Defence Association (PDA) has called on GP practicesto ensure that all healthcare professionals they employ, including pharmacists, benefit from the 7.2% funding boost they received under a newly agreed contract.

GP employers are encouraged to improve “job security, pay and conditions” for employees with this increased funding.

Keep ReadingShow less
Fourth Shift: Investment in Innovative Medicines Crucial for NHS 10-Year Plan Success

Medicines should be viewed as an investment rather than a cost

gettyimages

ABPI wants to see a ‘fourth shift’ in NHS 10-Year Health Plan


The Association of the British Pharmaceutical Industry (ABPI) has called on the government to increase investment in innovative medicines and vaccines, describing it as a crucial “fourth shift” necessary to ensure the NHS is fit for the future.

Keep ReadingShow less
Asda pharmacy launches UK’s first adult earache service

Asda makes ear health more accessible for everyone

gettyimages

Asda pharmacy launches £25 adult earache service

British supermarket chain Asda has launched the “UK’s first” adult earache service, aiming to reduce the burden on NHS services by eliminating the need for a GP appointment.

Priced at £25, the service allows patients aged 18 and over to book same-day appointments with qualified Asda pharmacists at any of its 226 pharmacies in England.

Keep ReadingShow less
Dr Penelope Dash new chair of NHS England

Dr Penny Dash is currently the chair of the NHS North West London Integrated Care Board

parliamentlive

Dr Penelope Dash appointed as new chair of NHS England

Dr Penny Dash has been appointed as the next chair of NHS England following an open public appointment process.

She will succeed Richard Meddings, who is set to step down next month, and her four-year term begins on April 1, 2025.

Keep ReadingShow less